Kolexia
Houessinon Aline
Oncologie médicale
Centre Hospitalier de Abbeville
Abbeville, France
45 Activités
36 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Carcinome épidermoïde Tumeurs de la tête et du cou Tumeurs du foie Carcinome hépatocellulaire Carcinome épidermoïde de la tête et du cou Tumeurs épidermoïdes Dysbiose Chordome

Industries

MSD
6 collaboration(s)
Dernière en 2022
Ipsen
3 collaboration(s)
Dernière en 2021
Merck-Serono
3 collaboration(s)
Dernière en 2023
BMS
3 collaboration(s)
Dernière en 2023

Dernières activités

NIVOCHIMLOC: Intratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head and Neck Cancers
Essai Clinique (CHU Amiens-Picardie)   28 avril 2023
129P Molecular screening and early phase trial inclusion for head and neck squamous cell carcinoma patients
Molecular Analysis for Precision Oncology Congress 2022 14-16 October 2022   01 octobre 2022
695P Effectiveness and quality-of-life (QoL) data from real-world study (ProNiHN) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of head and neck (R/M SCCHN) treated with nivolumab (nivo) in France
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors.
Therapeutic advances in medical oncology   15 mars 2021
Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 Cases.
Case reports in oncology   14 juillet 2020
Molecular screening in advanced cancer patients with head and neck cancers: A retrospective analysis of the MOSCATO-01 trial
Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany   01 octobre 2018
Squamous Cell Carcinoma Antigen-encoding Genes as Potentially Useful Markers for the Stratification of HNSCC Tumours.
Anticancer research   12 mars 2018
Importance des variations spectrales durant 36 mois de suivi longitudinal IRM et SRM de 80 patients atteints de glioblastomes traités
44th Congress of the SFNR   01 mars 2017
Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma.
Clinica chimica acta; international journal of clinical chemistry   11 octobre 2016
Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.
Molecular cancer   16 mai 2016